169
Participants
Start Date
May 31, 2007
Primary Completion Date
April 30, 2008
Study Completion Date
April 30, 2008
Colesevelam HCl
coleveselam tablets 625 mg; 6 tablets/day
rosiglitazone maleate
rosiglitazone tablets 4mg
sitagliptin phosphate
sitagliptin phosphate tablets 100mg/day
La Mesa
Los Angeles
Los Gatos
San Antonio
Chiefland
Gary
Baltimore
Dearborn
West Bloomfield
Las Vegas
Yonkers
Lexington
Winston-Salem
Munroe Falls
Zaneville
Portland
Jersey Shore
Clemson
Harriman
Dallas
Lead Sponsor
Daiichi Sankyo
INDUSTRY